Mining the malignant ascites proteome for pancreatic cancer biomarkers

Proteomics

Volumn 11, Issue 23, 2011, Pages 4551-4558

  Kosanam, Hari ^a,b,c   Makawita, Shalini ^a,c   Judd, Bramford ^a   Newman, Alice ^d   Diamandis, Eleftherios P ^a,c,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b Proteomic Methods Inc   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d PRINCESS MARGARET HOSPITAL   (Canada)

^e UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Biomarkers; Biomedicine; Lectin chromatography; MS; Multidimensional chromatography; Pancreatic cancer

Indexed keywords

BIOLOGICAL MARKER; PROTEOME;

ADULT; AFFINITY CHROMATOGRAPHY; AGED; ARTICLE; ASCITES; ASCITES FLUID; CANCER TISSUE; CASE REPORT; CONTROLLED STUDY; FEMALE; GEL PERMEATION CHROMATOGRAPHY; HUMAN; ION EXCHANGE CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DATABASE; PROTEIN GLYCOSYLATION;

AGED; ASCITES; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREAS; PANCREATIC NEOPLASMS; PROTEOME; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL;

EID: 81855166737     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201100264     Document Type: Article

References (29)

1. Jemal, A., Bray, F., Center, M. M., Ferlay, J. et al., Global cancer statistics. CA Cancer J. Clin. 2011, 61, 69-90.
2. Etzioni, R., Urban, N., Ramsey, S., McIntosh, M. et al., The case for early detection. Nat. Rev. Cancer 2003, 3, 243-252.
3. Goonetilleke, K. S., Siriwardena, A. K., Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer. Eur. J. Surg. Oncol. 2007, 33, 266-270.
4. Marrelli, D., Caruso, S., Pedrazzani, C., Neri, A. et al., CA19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions. Am. J. Surg. 2009, 198, 333-339.
5. Soriano, A., Castells, A., Ayuso, C., Ayuso, J. R. et al., Preoperative staging and tumor resectability assessment of pancreatic cancer: prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging, and angiography. Am. J. Gastroenterol. 2004, 99, 492-501.
6. Irisawa, A., Sato, A., Sato, M., Ikeda, T. et al., Early diagnosis of small pancreatic cancer: role of endoscopic ultrasonography. Dig. Endosc. 2009, 21, S92-S96.
7. Mendieta Zeron, H., Garcia Flores, J. R., Romero Prieto, M. L., Limitations in improving detection of pancreatic adenocarcinoma. Future Oncol. 2009, 5, 657-668.
8. Adam, R. A., Adam, Y. G., Malignant ascites: past, present, and future. J. Am. Coll. Surg. 2004, 198, 999-1011.
9. Tamsma, J. T., Keizer, H. J., Meinders, A. E., Pathogenesis of malignant ascites: Starling's law of capillary hemodynamics revisited. Ann. Oncol. 2001, 12, 1353-1357.
10. Zervos, E. E., Osborne, D., Boe, B. A., Luzardo, G. et al., Prognostic significance of new onset ascites in patients with pancreatic cancer. World J. Surg. Oncol. 2006, 4, 16-22.
11. Kuk, C., Kulasingam, V., Gunawardana, C. G., Smith, C. R. et al., Mining the ovarian cancer ascites proteome for potential ovarian cancer biomarkers. Mol. Cell. Proteomics 2009, 8, 661-669.
12. Kuk, C., Gunawardana, C. G., Soosaipillai, A., Kobayashi, H. et al., Nidogen-2: a new serum biomarker for ovarian cancer. Clin. Biochem. 2010, 43, 355-361.
13. Gortzak-Uzan, L., Ignatchenko, A., Evangelou, A. I., Agochiya, M. et al., A proteome resource of ovarian cancer ascites: integrated proteomic and bioinformatic analyses to identify putative biomarkers. J. Proteome Res. 2008, 7, 339-351.
14. Metzgar, R. S., Rodriguez, N., Finn, O. J., Lan, M. S. et al., Detection of a pancreatic cancer-associated antigen (DU-PAN-2 antigen) in serum and ascites of patients with adenocarcinoma. Proc. Natl. Acad. Sci. USA 1984, 81, 5242-5246.
15. Siegmund, R., Kiehntopf, M., Deufel, T., Evaluation of two different albumin depletion strategies for improved analysis of human CSF by SELDI-TOF-MS. Clin. Biochem. 2009, 42, 1136-1143.
16. Bellei, E., Bergamini, S., Monari, E., Fantoni, L. I. et al., High-abundance proteins depletion for serum proteomic analysis: concomitant removal of non-targeted proteins. Amino Acids 2011, 40, 145-156.
17. Cho, C. K., Shan, S. J., Winsor, E. J., Diamandis, E. P., Proteomics analysis of human amniotic fluid. Mol. Cell. Proteomics 2007, 6, 1406-1415.
18. Magagnotti, C., Fermo, I., Carletti, R. M., Ferrari, M., Bachi, A., Comparison of different depletion strategies for improving resolution of the human urine proteome. Clin. Chem. Lab Med. 2010, 48, 531-535.
19. Granvogl, B., Gruber, P., Eichacker, L. A., Standardisation of rapid in-gel digestion by mass spectrometry. Proteomics 2007, 7, 642-654.
20. Batruch, I., Lecker, I., Kagedan, D., Smith, C. R. et al., Proteomic analysis of seminal plasma from normal volunteers and post-vasectomy patients identifies over 2000 proteins and candidate biomarkers of the urogenital system. J. Proteome Res. 2011, 10, 941-953.
21. Pavlou, M. P., Kulasingam, V., Sauter, E. R., Kliethermes, B., Diamandis, E. P., Nipple aspirate fluid proteome of healthy females and patients with breast cancer. Clin. Chem. 2010, 56, 848-855.
22. Harsha, H. C., Kandasamy, K., Ranganathan, P., Rani, S. et al., A compendium of potential biomarkers of pancreatic cancer. PLoS Med. 2009, 6, e1000046.
23. Bunger, S., Laubert, T., Roblick, U. J., Habermann, J. K., Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview. J. Cancer Res. Clin. Oncol. 2011, 137, 375-389.
24. Schultz, J. D., Rotunno, S., Erben, P., Sommer, J. U. et al., Down-regulation of MMP-2 expression due to inhibition of receptor tyrosine kinases by imatinib and carboplatin in HNSCC. Oncol. Rep. 2011, 25, 1145-1151.
25. Moniaux, N., Chakraborty, S., Yalniz, M., Gonzalez, J. et al., Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia. Br. J. Cancer 2008, 98, 1540-1547.
26. Rong, Y., Jin, D., Hou, C., Hu, J. et al., Proteomics analysis of serum protein profiling in pancreatic cancer patients by DIGE: up-regulation of mannose-binding lectin 2 and myosin light chain kinase 2. BMC Gastroenterol. 2010, 10, 68-77.
27. Serra, S., Asa, S. L., Bamberger, A. M., Wagener, C., Chetty, R., CEACAM1 expression in pancreatic endocrine tumors. Appl. Immunohistochem. Mol. Morphol. 2009, 17, 286-293.
28. Saha, S., Harrison, S. H., Shen, C., Tang, H. et al., HIP2: an online database of human plasma proteins from healthy individuals. BMC Med. Genomics 2008, 1, 12-21.
29. Hortin, G. L., Sviridov, D., Anderson, N. L., High-abundance polypeptides of the human plasma proteome comprising the top 4 logs of polypeptide abundance. Clin. Chem. 2008, 54, 1608-1616.